admin | March 31, 2009
FR Solution
Comtex
UPPSALA, Sweden & WAUKESHA, Wis. & ST. PAUL, Minn., Mar 30, 2009 (BUSINESS WIRE) —-St. Jude Medical, Inc. (NYSE:STJ) and GE Healthcare today announced the worldwide commercial launch of the first fully integrated wireless solution for the measurement of Fractional Flow Reserve (FFR).
The new FFR solution, seamlessly integrated into existing cathlab infrastructure, will enable physicians and cathlab staff immediate access to FFR measurement without time consuming setup.
Category: Buffalo Heart Health |
No Comments »
Tags:
admin | March 31, 2009
EECP therapy improves peripheral endothelial function, reduces arterial stiffness and promotes coronary collateral growth
Results of Two Randomized Controlled Studies on Vasomedical EECP Therapy Presented at the American College of Cardiology (ACC) 58th Annual Scientific Session
EECP therapy improves peripheral endothelial function, reduces arterial stiffness and promotes coronary collateral growth
- Tuesday March 31, 2009, 11:02 am EDT
WESTBURY, N.Y.–(BUSINESS WIRE)–Vasomedical, Inc. (”Vasomedical”) (OTC: VASO.OB - News), a leader in the non-invasive treatment and management of cardiovascular diseases, today announced that two presentations on the beneficial effects of EECP® external counterpulsation therapy have just been presented at the 58th Annual Scientific Session of the American College of Cardiology in Orlando.
Category: Buffalo Heart Health |
No Comments »
Tags:
admin | March 30, 2009
By Steven Reinberg
HealthDay Reporter
SUNDAY, March 29 (HealthDay News) — A surgical procedure called ventricular reconstruction that doctors hoped would improve symptoms in people with heart failure does not seem to work, a new study has found.
The hope was that by isolating the damaged part of the left ventricle — the chamber of the heart that pumps blood to the body — people would see an improvement in symptoms and exercise capacity, and there would be fewer deaths and hospitalizations as well.
Category: Buffalo Heart Health |
No Comments »
Tags:
admin | March 30, 2009
By Em Brown
ORLANDO, Fla — March 29, 2009 — The clinical benefits of coronary artery bypass graft (CABG) surgery do not justify its higher cost at 1 year, researchers announced here at the American College of Cardiology (ACC) 58th Annual Scientific Session.
Principal investigator David J. Cohen, MD, MSc, Saint Luke’s Mid America Heart Institute and University of Missouri, Kansas City, Missouri, discussed the findings from the Synergy Between PCI With Taxus(R) and Cardiac Surgery (SYNTAX) trial here on March 28 at a late-breaking clinical trials session.
Category: Buffalo Heart Health |
No Comments »
Tags:
admin | March 30, 2009
ORLANDO, Fla. (Dow Jones)–The search for a better drug to raise good cholesterol has hit major setbacks, but one leading cardiologist says there’s still promise for this approach to heart disease.
Steve Nissen, chair of cardiovascular medicine at the Cleveland Clinic, told a cardiology conference Sunday there were seven “shots on goal” that could yield an advance in raising good cholesterol in coming years. They include experimental drugs in development at Merck & Co. (MRK) and Roche Holding AG (RHHBY).
“We think we’ve got to get back on the horse and keep trying,” Nissen, who has run cholesterol-drug trials for …
Category: Buffalo Heart Health |
No Comments »
Tags:
admin | March 30, 2009
CASTLE ROCK, Colo. — The kitchen is where local firefighters are learning to save their own lives.
Mixed between the fresh vegetables and cooking utensils they’re finding recipes for healthier hearts.
“We’re going to show those who take care of others how to take care of themselves,” said Dr. Richard Collins.
Collins is a cardiologist with South Denver Cardiology Associates. He teaches a unique way to improve heart health.
Known as the Cooking Cardiologist, Collins offers cooking classes to teach patients how to easily change their eating habits.
Category: Buffalo Heart Health |
No Comments »
Tags:
admin | March 30, 2009
Arena Obesity Drug Helps Patients Lose Weight, Without Heart Damage
Luke Timmerman 3/30/09
[[Updated last paragraph: 9:38 am EDT]] Arena Pharmaceuticals has some good news this morning, although it will take some time to sort out how good. The San Diego-based biotech company said its experimental drug for obesity was able to reach its goals for helping people lose weight, without the side effect of damaging heart valves like the fen-phen drug combination did in the 1990s. That’s an important test for Arena’s drug, lorcaserin, because it’s designed to curb appetite like fen-phen while avoiding similar receptors on heart valves.
Category: Buffalo Heart Health |
No Comments »
Tags:
admin | March 30, 2009
DURHAM, NC - A surgical procedure to resize an enlarged, weakened heart muscle during coronary bypass surgery for heart failure adds cost and risk but doesn’t offer patients any additional benefit when compared with those who received bypass procedure alone, according to researchers from the Duke Clinical Research Institute (DCRI).
Duke researchers examined quality of life and cost issues among 1000 patients with heart failure enrolled in the STICH trial (Surgical Treatment for Ischemic Heart Failure), a multi-center, international clinical trial that compared clinical outcomes between patients who had bypass surgery alone with those who had bypass combined with a second procedure, called surgical ventricular reconstruction (SVR).
Category: Buffalo Heart Health |
No Comments »
Tags:
admin | March 30, 2009
LOCKPORT: Free health fair offers risk spotting for diabetes, heart disease, certain cancers.
Staff Reports
Lockport Union-Sun & Journal
The incidence of diabetes is rising sharply in our part of the world.
The federal Centers For Disease Control predicts 1 of every 3 children born in the United States will develop diabetes in their lifetime. Among African-American children, the predicted rate is 2 in 5.
Statistics indicate 1 million New York residents already are diagnosed with Type II diabetes — and up to 500,000 more could have it, but they don’t receive life-saving treatment because they haven’t been tested.
Category: Buffalo Heart Health |
No Comments »
Tags:
admin | March 30, 2009
WASHINGTON: Most Americans consume more than double the amount of their daily recommended salt intake, says a new study.
A study by the Centres for Disease Control (CDC) and Prevention shows that more than two out of three adults are in population groups that should consume no more than 1,500 mg per day of sodium.
During 2005-2006, the estimated average intake of sodium for people in the US aged two or more years was 3,436 mg per day.
A diet high in sodium increases the risk of having higher blood pressure, a major cause for heart disease and stroke, which are the first and third leading causes of death in the US.
Category: Buffalo Heart Health |
No Comments »
Tags:
